APP and amyloidosis: However, we recently found peripheral IR in an early-asymptomatic phase of the disease in young AD-relevant amyloidosis mice overexpressing the human APP with the Swedish double mutation [B6.Cg-Tg(Thy1-APP)3Somm/J, referred to as APP23].